342 related articles for article (PubMed ID: 25850019)
1. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
[TBL] [Abstract][Full Text] [Related]
2. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
[TBL] [Abstract][Full Text] [Related]
4. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
[TBL] [Abstract][Full Text] [Related]
8. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
[TBL] [Abstract][Full Text] [Related]
9. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.
Azman AS; Parker LA; Rumunu J; Tadesse F; Grandesso F; Deng LL; Lino RL; Bior BK; Lasuba M; Page AL; Ontweka L; Llosa AE; Cohuet S; Pezzoli L; Sodjinou DV; Abubakar A; Debes AK; Mpairwe AM; Wamala JF; Jamet C; Lessler J; Sack DA; Quilici ML; Ciglenecki I; Luquero FJ
Lancet Glob Health; 2016 Nov; 4(11):e856-e863. PubMed ID: 27765293
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
[TBL] [Abstract][Full Text] [Related]
13. Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
Islam MT; Chowdhury F; Qadri F; Sur D; Ganguly NK
Vaccine; 2020 Feb; 38 Suppl 1():A127-A131. PubMed ID: 31301917
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
[TBL] [Abstract][Full Text] [Related]
16. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
[TBL] [Abstract][Full Text] [Related]
17. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
Ali M; Debes AK; Luquero FJ; Kim DR; Park JY; Digilio L; Manna B; Kanungo S; Dutta S; Sur D; Bhattacharya SK; Sack DA
PLoS Med; 2016 Sep; 13(9):e1002120. PubMed ID: 27622507
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India.
Mahalanabis D; Lopez AL; Sur D; Deen J; Manna B; Kanungo S; von Seidlein L; Carbis R; Han SH; Shin SH; Attridge S; Rao R; Holmgren J; Clemens J; Bhattacharya SK
PLoS One; 2008 Jun; 3(6):e2323. PubMed ID: 18523643
[TBL] [Abstract][Full Text] [Related]
20. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
